Takeda Pharmaceutical Co Ltd
NYSE:TAK
Takeda Pharmaceutical Co Ltd
NYSE:TAK
Price:
18.24
USD
1.84%
Market Cap:
$57.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
T
|
Top Ships Inc
AMEX:TOPS
|
GR |
|
U
|
Uranium Energy Corp
AMEX:UEC
|
US |
|
O
|
Orange County Bancorp Inc
NASDAQ:OBT
|
US |
|
S
|
Stellar Bancorp Inc
NYSE:STEL
|
US |
|
N
|
Nutrien Ltd
NYSE:NTR
|
CA |
|
Uday Jewellery Industries Ltd
BSE:539518
|
IN |
|
S
|
Siav SpA
MIL:SIAV
|
IT |
|
X
|
Xinjiang Qingsong Building Materials and Chemicals Group Co Ltd
SSE:600425
|
CN |
|
Huatu Cendes Co Ltd
SZSE:300492
|
CN |
|
Latvijas Gaze AS
F:UMA
|
LV |
|
I
|
Intel Corp
XETRA:INL
|
US |
Multiples-Based Value
The Multiples-Based Value of one
TAK
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 18.24 USD,
Takeda Pharmaceutical Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TAK Multiples-Based Value
LOCKED
Multiples Across Competitors
TAK Competitors Multiples
Takeda Pharmaceutical Co Ltd Competitors
Takeda Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
9T USD | 2 | 79.9 | 10.2 | 26.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.9 | 40.6 | 27.5 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.2 | 21.7 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.5 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
